Evidence map›Paper›PMID 25831060›Full record

ReviewOmics : a journal of integrative biology2015

The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders.

Roger Higdon, Rachel K Earl, Larissa Stanberry, Caitlin M Hudac, Elizabeth Montague, Elizabeth Stewart, Imre Janko, John Choiniere, William Broomall, Natali Kolker and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in Omics : a journal of integrative biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. The Neuroimmunology of Autism.Molecular neurobiology · 2025
    Review
  4. Article
  5. Predicting Preterm Birth Using Proteomics.Clinics in perinatology · 2024
    Review
  6. Article
  7. Omics and Multi-Omics in IBD: No Integration, No Breakthroughs.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Integration strategies of multi-omics data for machine learning analysis.Computational and structural biotechnology journal · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Co-occurring medical conditions among individuals with ASD-associated disruptive mutations.Children's health care : journal of the Association for the Care of Children's Health · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Roger Higdon1 Bioinformatics and High-Throughput Analysis Laboratory, Seattle Children's Research Institute , Seattle, Washington.
Rachel K Earl
Larissa Stanberry
Caitlin M Hudac
Elizabeth Montague
Elizabeth Stewart
Imre Janko
John Choiniere
William Broomall
Natali Kolker
Raphael A Bernier
Eugene Kolker
Seattle Children's Hospital · USUniversity of Washington · USAlliance Data (United States) · US

Funding

Multimodal Developmental Neurogenetics of Females with ASDR01MH100028 · NIMH · YALE UNIVERSITY · PI Allison Elizabeth Jack, LAUREN KENWORTHY · 2012 to 2026
$37.8M
Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Thyroid Regulation in the Developing HeartR01HL060666 · NHLBI · UNIVERSITY OF WASHINGTON · PI PORTMAN, MICHAEL A · 1998 to 2013
$4.7M
Next Generation Gene Discovery in Familial AutismR01MH092367 · NIMH · UNIVERSITY OF WASHINGTON · PI BRKANAC, ZORAN · 2011 to 2015
$3.3M
Phenotypic Characterization of Gene Disrupting Mutations in ASDR01MH100047 · NIMH · UNIVERSITY OF WASHINGTON · PI BERNIER, RAPHAEL A · 2014 to 2018
$2.1M
NHLBI NIH HHS R01-HL-060666-10A1NIMH NIH HHS R01 MH 092367NIMH NIH HHS R01 MH100028NIMH NIH HHS R01 MH101221
6 · The paper itself

Abstract

Complex diseases are caused by a combination of genetic and environmental factors, creating a difficult challenge for diagnosis and defining subtypes. This review article describes how distinct disease subtypes can be identified through integration and analysis of clinical and multi-omics data. A broad shift toward molecular subtyping of disease using genetic and omics data has yielded successful results in cancer and other complex diseases. To determine molecular subtypes, patients are first classified by applying clustering methods to different types of omics data, then these results are integrated with clinical data to characterize distinct disease subtypes. An example of this molecular-data-first approach is in research on Autism Spectrum Disorder (ASD), a spectrum of social communication disorders marked by tremendous etiological and phenotypic heterogeneity. In the case of ASD, omics data such as exome sequences and gene and protein expression data are combined with clinical data such as psychometric testing and imaging to enable subtype identification. Novel ASD subtypes have been proposed, such as CHD8, using this molecular subtyping approach. Broader use of molecular subtyping in complex disease research is impeded by data heterogeneity, diversity of standards, and ineffective analysis tools. The future of molecular subtyping for ASD and other complex diseases calls for an integrated resource to identify disease mechanisms, classify new patients, and inform effective treatment options. This in turn will empower and accelerate precision medicine and personalized healthcare.

Indexed as

GenomicsPrecision MedicineAutism Spectrum DisorderCluster AnalysisHumansMolecular Typing

Identifiers

PMID25831060
PMCPMC4389910
OpenAlexW2040972146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.